I-Retaglutide iyisidakamizwa esisha se-dipeptidyl peptidase-4 (DPP-4) inhibitor class hypoglycemic engavimbela ukuwohloka kwe-glucagon-like peptide-1 (GLP-1) kanye ne-glucose encike ku-insulin-ekhulula i-polypeptide (GIP) nge-enzyme ye-DPP-4 emathunjini nasegazini, ngokwandisa umsebenzi wabo we-insulin, ngokwandisa umsebenzi wabo we-pancreas. Izinga eliyisisekelo le-insulin yokuzila, kuyilapho kunciphisa ukukhiqizwa kwe-glucagon ngamaseli e-pancreatic α, ngaleyo ndlela kulawule ngempumelelo ushukela wegazi we-postprandial. Isebenza kahle ngokuya ngomphumela we-hypoglycemic, ukubekezelelana, nokuhambisana.